Edf: 2022 ANNUAL RESULTS: SIGNIFICANT DOWNTURN IN RESULTS
2022 ANNUAL RESULTS SIGNIFICANT DOWNTURN IN RESULTS IN A CONTEXT OF FRENCH POWER OUTPUT SHORTFALL AND HIGH MARKET
Globe Newswire17-02-2023, 14:09
APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 for the Diagnosis of Progressive Supranuclear Palsy 22-05-2024, 07:00